watch
Regenicin, Inc.

Regenicin, Inc.

Sector: Commercial Physical And Biological Research Region: NJ, United States


: | OTC Markets: RGIN


Similar to: Cerep SA, Medivir AB, Exelixis, Inc.

Regenicin, Inc. is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. It intends to develop and commercialize a potentially lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures. The company was founded on September 6, 2007 and is headquartered in Little Falls, NJ.

News & Analysis

You may also be interested in: